EMA and FDA create pharmacovigilance 'cluster' (PMLive, 20 February 2014)

The European Medicines Agency (EMA) and its US counterpart the Food and Drug Administration (FDA) have resolved to create a 'pharmacovigilence cluster', involving monthly meetings to improve information-sharing between the two organisations.

Full article